Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v6-FR | Version v3-EN | |
---|---|---|
Language | French | English |
Date Updated | 2020-10-28 | 2020-06-29 |
Drug Identification Number | 02258595 | 02258595 |
Brand name | HUMIRA VIAL | HUMIRA VIAL |
Common or Proper name | HUMIRA (ADALIMUMAB) VIAL | HUMIRA (ADALIMUMAB) VIAL |
Company Name | ABBVIE CORPORATION | ABBVIE CORPORATION |
Ingredients | ADALIMUMAB | ADALIMUMAB |
Strength(s) | 40MG | 40MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | SUBCUTANEOUS | SUBCUTANEOUS |
Packaging size | 2 x 0.8mL vial (40mg/0.8mL) | 2 x 0.8mL vial (40mg/0.8mL) |
ATC code | L04AB | L04AB |
ATC description | IMMUNOSUPPRESSANTS | IMMUNOSUPPRESSANTS |
Reason for discontinuation | Business reasons | Business reasons |
Anticipated discontinuation date | 2020-11-02 | 2020-12-30 |
Actual discontinuation date | ||
Remaining supply date | 2020-11-02 | 2020-12-30 |
Discontinuation status | To be discontinued | To be discontinued |
Discontinuation decision reversal | no | no |
Tier 3 Status | No | No |
Information on remaining supply | ||
Company comments | The HUMIRA 40mg vial will be phased out by November 2nd 2020. AbbVie has now introduced the new HUMIRA 20 mg pre-filled syringe for pediatric patients prescribed HUMIRA 20mg. HUMIRA 40mg in PEN and pre-filled syringe are still available for pediatric patients prescribed HUMIRA 40mg. | The HUMIRA 40mg vial will be phased out by the end of December 2020. AbbVie will introduce the new HUMIRA 20 mg pre-filled syringe for pediatric patients prescribed HUMIRA 20mg. HUMIRA 40mg in PEN and pre-filled syringe are still available for pediatric patients prescribed HUMIRA 40mg / HUMIRA 40mg Vial sera discontinue à la fin Décembre 2020. AbbVie mettra sur le marché, le HUMIRA 20 mg seringues préremplies pour usage pédiatrique. HUMIRA 40mg auto-injecteur, est toujours disponible pour les patients pédiatriques prescrits avec HUMIRA 40mg. |
Health Canada comments |